ID: ALA5271915

Max Phase: Preclinical

Molecular Formula: C13H16N2O

Molecular Weight: 216.28

Associated Items:

Representations

Canonical SMILES:  CCCCOc1cc2ccccc2nc1N

Standard InChI:  InChI=1S/C13H16N2O/c1-2-3-8-16-12-9-10-6-4-5-7-11(10)15-13(12)14/h4-7,9H,2-3,8H2,1H3,(H2,14,15)

Standard InChI Key:  XASJHNZIAAPRGU-UHFFFAOYSA-N

Associated Targets(Human)

Toll-like receptor 8 1853 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 216.28Molecular Weight (Monoisotopic): 216.1263AlogP: 3.00#Rotatable Bonds: 4
Polar Surface Area: 48.14Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.66CX LogP: 3.06CX LogD: 3.05
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.80Np Likeness Score: -0.47

References

1. Kaushik D, Kaur A, Petrovsky N, Salunke DB..  (2021)  Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles.,  12  (7.0): [PMID:34355178] [10.1039/D1MD00031D]

Source